Clinical Endpoints For Psoriasis

Halaven of Eisai (TM) (Eribulin) receives positive CHMP opinion for use in metastatic breast cancer HATFIELD, England, January 21, 2011 / PRNewswire / The Committee for Medicinal Products for Human Use (CHMP), the Scientific Committee of the European Medicines Agency (EMA), today a positive opinion for the use of Eisai Europe Ltd. 's …

Generic Drug Product Development: Specialty Dosage Forms (Drugs and the Pharmaceutical Sciences) $54.99 Exploring the more difficult demonstration of pharmaceutical equivalence and bioequivalence for specialty drug products, this title details various approaches and strategies for manufacturers to demonstrate the therapeutic equivalence of generic specialty drug products to brand name alternatives. It discusses the measurement of drug product quality and performance, as well as the regulatory and s…